Zobrazeno 1 - 10
of 77
pro vyhledávání: '"Mediastinal Hodgkin Lymphoma"'
Autor:
Bouziane, Jihane a, Loap, Pierre a, Cao, Kim a, Pauly, Lea b, Fourquet, Alain a, Kirova, Youlia a, ⁎
Publikováno v:
In European Journal of Surgical Oncology March 2025 51(3)
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ferrat Dincoglan, Hakan Gamsiz, Omer Sager, Fatih Ozcan, Onurhan Colak, Murat Beyzadeoglu, Selcuk Demiral, Bora Uysal, Bahar Dirican
Publikováno v:
Journal of Surgery and Surgical Research. 6:106-109
Lymphomas constitute the most frequent hematologic malignancies. HL is a rare type of B cell lymphoma featured with Reed Sternberg cells. Treatment of HL may be considered among the greatest success stories in oncology.
Autor:
Michael Joyce, Eric Sandler, William B. Slayton, Raymond B. Mailhot Vega, Bradford S. Hoppe, Zuofeng Li, Nancy P. Mendenhall, S. Flampouri, Howard M. Katzenstein
Publikováno v:
International Journal of Particle Therapy, Vol 6, Iss 4, Pp 1-6 (2020)
International Journal of Particle Therapy
International Journal of Particle Therapy
Background Local relapse is a predominant form of recurrence among pediatric patients with Hodgkin lymphoma (PHL). Although PHL radiotherapy doses have been approximately 20 Gy, adults with Hodgkin lymphoma receiving 30 to 36 Gy experience fewer in-f
Autor:
L.B. Stick, Maja V. Maraldo, Laura Ann Rechner, Stephanie R. Rice, Ivan R. Vogelius, Søren M. Bentzen, Arezoo Modiri, Marianne C. Aznar, Amit Sawant, Lena Specht
Publikováno v:
Rechner, L A, Modiri, A, Stick, L B, Maraldo, M V, Aznar, M C, Rice, S R, Sawant, A, Bentzen, S M, Vogelius, I R & Specht, L 2020, ' Biological optimization for mediastinal lymphoma radiotherapy-a preliminary study ', Acta Oncologica, vol. 59, no. 8, pp. 879-887 . https://doi.org/10.1080/0284186X.2020.1733654
Acta Oncologica (Stockholm, Sweden)
Acta Oncologica (Stockholm, Sweden)
Purpose: In current radiotherapy (RT) planning and delivery, population-based dose-volume constraints are used to limit the risk of toxicity from incidental irradiation of organs at risks (OARs). However, weighing tradeoffs between target coverage an
Publikováno v:
Cancer/Radiothérapie. 23:922-925
The purpose of this work was reducing treatment-related toxicity for Hodgkin lymphomas using practical procedure inspired by the ILROG guidelines. Reporting the first case of localized Hodgkin lymphoma treated with protontherapy in France. A 24-year-
Autor:
Martín J. García-González, Juan Lacalzada-Almeida, Javier García-Niebla, Néstor Báez-Ferrer, María Manuela Izquierdo-Gómez, Julio J. Ferrer-Hita, Pablo Jorge-Pérez, Carima Beyello-Belkasem, Alejandro de la Rosa-Hernández
Publikováno v:
The American Journal of Case Reports
Patient: Male, 48 Final Diagnosis: Late cardiac complications postradiotherapy Symptoms: Chest pain • dyspnea • syncope Medication: — Clinical Procedure: Diagnostic and therapeutic techniques in cardiology Specialty: Cardiology Objective: Unusu
Publikováno v:
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique. 25(8)
Purpose Protontherapy for mediastinal Hodgkin lymphoma reduces cardiac, lung and breast exposure, which may limit radiation-induced adverse events. While this technique is already widely implemented in the United-States, clinical experience is still
Autor:
Seita Yamasaki, Yuki Obayashi, Takeshi Harita, Hiroki Okamoto, Maiko Kuroda, Suguru Nishiuchi, Hidenori Kojima, Soichiro Enomoto, Hibiki Mima, Jiro Sakamoto, Hisashi Sakaguchi, Toshihiro Tamura, Hirokazu Kondo, Yukihiro Hamaguchi, Makoto Miyake, Akinori Tamura, Yodo Tamaki, Maki Hamasaki, Atsushi Iwakura
Publikováno v:
Internal Medicine
Aortic stenosis (AS), a late complication of thoracic radiation therapy for chest lesions, is often coincident with porcelain aorta or hostile thorax. We herein report a 59-year-old man with a history of mediastinal Hodgkin lymphoma treated with radi